Low-Dose Busulfan Reduces Human CD34<sup>+</sup> Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice.

Leonard, Alexis; Yapundich, Morgan; Nassehi, Tina; Gamer, Jackson; Drysdale, Claire M; Haro-Mora, Juan J; Demirci, Selami; Hsieh, Matthew M; Uchida, Naoya; Tisdale, John F

Low-Dose Busulfan Reduces Human CD34⁺ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice.

Leonard, Alexis; Yapundich, Morgan; Nassehi, Tina; Gamer, Jackson; Drysdale, Claire M; Haro-Mora, Juan J; Demirci, Selami; Hsieh, Matthew M; Uchida, Naoya; Tisdale, John F.

Afiliação

Leonard A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Yapundich M; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Nassehi T; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Gamer J; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Drysdale CM; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Haro-Mora JJ; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Demirci S; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Hsieh MM; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Uchida N; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.